Home / World Marketplace / Archive by category Global Health & Biotech (Page 12)

Archive by category Global Health & Biotech

Teva to Host Conference Call to Discuss Data from the Completed Phase 3 SOLARIS Trial For Olanzapine LAI (TEV-‘749) on September 22, 2025 After Presentations at the Psych Congress Annual meeting

TEL AVIV, Israel, Sept. 16, 2025 (Korea Bizwire) – Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced plans to present data from the completed phase 3 SOLARIS trial at the 2025 Psych Congress Annual Meeting, taking place from September 17 – 21, 2025, in San Diego, California. Teva will also host a conference [...]

Philips intends to extend maturity of forward purchases of 4 million shares for long-term incentive plans

September 15, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) announces today that it intends to extend the settlement of two forward contracts for 2 million long-term incentive plans shares each as part of the share repurchase program earlier announced on June 14, 2023. The planned extension will postpone the original maturity dates in Q4 2025 [...]

OPEN Health Validates Net-Zero Targets with Science Based Targets initiative (SBTi)

London & New York, Sept. 15, 2025 (Korea Bizwire) – OPEN Health, a global leader in medical affairs, health economics and outcomes research (HEOR) and market access, patient engagement, and consulting services, today announced that its near-term and net-zero emission reduction targets have been officially validated by the Science Based Targets initiative (SBTi). This milestone affirms [...]

Smith+Nephew unveils major clinical evidence and patient access updates for its REGENETEN™ Bioinductive Implant

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces new evidence and market updates that highlight the clinical performance of its REGENETEN Bioinductive Implant and support its further adoption. Substantial investment into research to expand access and indications have led to these important results designed to help surgeons treat more patients who suffer from [...]

Philips and Masimo announce innovation partnership to advance access to patient monitoring measurement technologies

September 11, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Masimo (NASDAQ: MASI) today announced that the two companies have renewed their multi-year strategic collaboration, marking a fresh chapter in their long-standing partnership. With a shared commitment to innovation and expanding access to high-quality, connected care, the two companies [...]

Kyowa Kirin Announces Late-Breaking Abstract Presentation at the European Academy of Dermatology and Venerology Congress

Princeton, NJ and TOKYO, Sept. 11, 2025 (Korea Bizwire) — Kyowa Kirin Co., Ltd. (TSE: 4151) today announced that results of the Phase 3 ROCKET-SHUTTLE trial of rocatinlimab, an investigational T-cell rebalancing therapy, will be presented as a late breaking oral presentation at the European Academy of Dermatology and Venerology (EADV) 2025 Annual Meeting to [...]

Bioptimus Assembles Elite Scientific Advisory Board to Build Next-Gen AI Models for Biology

Eight internationally renowned experts join Bioptimus to pioneer large-scale foundation models that will transform science and medicine PARIS, Sept. 11, 2025 (Korea Bizwire) – Bioptimus, the pioneering start-up building the world’s first universal foundation model for biology, today announced the formation of its Scientific Advisory Board (SAB), bringing together some of the most influential minds [...]

Sarat Ventures Y Innovations Biotech Fund to Invest in Early-Stage Companies with a focus in Saudi Arabia and the MENA Region

LONDON, Sept. 10, 2025 (Korea Bizwire) — In a historic step toward positioning Saudi Arabia as a global hub for biotechnology, Sarat Ventures Y Innovations Biotech Fund (UK) announced today the launch of a biotech fund, anchored by Allocator One, anticipated to invest roughly $50M in biotech companies with strategic connections to the Saudi Arabian [...]

Wellcome Leap and Pivotal Commit $100 Million to Women’s Health Research to Deliver Breakthroughs in Years, Not Decades

Partnership brings Leap’s total investment to a quarter billion dollars – advancing toward a $1 billion goal to transform outcomes for women worldwide SAN DIEGO, Sept. 10, 2025 (Korea Bizwire) — Wellcome Leap, a U.S. non-profit, and Pivotal, a group of organizations founded by Melinda French Gates, today announced a $100 million partnership to accelerate [...]

Teva’s Emrusolmin Granted U.S. FDA Fast Track Designation for Treatment of Multiple System Atrophy

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a different kind of global biopharmaceutical leader, one that operates across the full spectrum of innovation to reliably deliver medicines to patients worldwide. (Image from Teva webpage) Teva received Fast Track designation from the U.S. Food and Drug Administration for emrusolmin (TEV-56286), an investigational treatment for [...]